Local, Sustained, and Targeted Co-Delivery of MEK Inhibitor and Doxorubicin Inhibits Tumor Progression in E-Cadherin-Positive Breast Cancer

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Pharmaceutics

Topics

Chemistry

Biochemistry

Medicine

Internal Medicine

Biomaterials

Show all topics

DOI

10.3390/pharmaceutics16080981

License

CC-BY

Other Formats

PDF